- Home
- QGEN vs ACI Comparison
QGEN vs ACI Comparison
Compare QGEN & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | ACI |
|---|---|---|
| Founded | 1986 | 1860 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.6B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QGEN | ACI |
|---|---|---|
| Price | $45.06 | $17.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $49.74 | $24.14 |
| AVG Volume (30 Days) | 1.2M | ★ 8.7M |
| Earning Date | 11-04-2025 | 01-07-2026 |
| Dividend Yield | 3.34% | ★ 3.46% |
| EPS Growth | ★ 331.20 | N/A |
| EPS | ★ 1.84 | 1.69 |
| Revenue | $2,070,781,000.00 | ★ $81,370,600,000.00 |
| Revenue This Year | $7.12 | $4.87 |
| Revenue Next Year | $6.13 | $0.53 |
| P/E Ratio | $24.59 | ★ $10.26 |
| Revenue Growth | ★ 5.32 | 2.08 |
| 52 Week Low | $37.63 | $16.70 |
| 52 Week High | $51.88 | $23.20 |
Technical Indicators
Market Signals| Indicator | QGEN | ACI |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 43.38 |
| Support Level | $45.55 | $17.05 |
| Resistance Level | $47.48 | $17.54 |
| Average True Range (ATR) | 0.59 | 0.37 |
| MACD | -0.17 | -0.05 |
| Stochastic Oscillator | 11.63 | 23.90 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.